tablets 是什么意思，中文意思 | 片剂英文怎么说医学英语中英文词汇翻译

Dissolution Testing of Sublingual Tablets: A Novel In Vitro Method

O Rachid, M Rawas-Qalaji, FER Simons… - AAPS PharmSciTech, 2011 - Springer
Received 22 December 2010; accepted 4 April 2011 Abstract. In the sublingual (SL) cavity, compared
with the gastrointestinal tract, tablets are subjected to minimal physiological agitation, and a limited
volume of saliva is available to facilitate disintegration and dissolution. None of the official ...
Related articles - All 2 versions

[HTML] … indicating liquid chromatographic determination of ebastine in pharmaceuticals after pre column derivatization: Application to tablets and content uniformity …

[HTML] from nih.govF Ibrahim, MKS El-Din, MI Eid… - Chemistry Central …, 2011 - ncbi.nlm.nih.gov
An accurate, simple, sensitive and selective reversed phase liquid chromatographic method
has been developed for the determination of ebastine in its pharmaceutical preparations. The
proposed method depends on the complexation ability of the studied drug with Zn 2+ ...
Cited by 1 - Related articles - All 4 versions

Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and …

[HTML] from thelancet.itG Giovannoni, S Cook, K Rammohan… - The Lancet …, 2011 - Elsevier
On the basis of various clinical and MRI measurements, the phase 3 Cladribine Tablets Treating
Multiple Sclerosis Orally (CLARITY) study in patients with relapsing–remitting multiple sclerosis
(RRMS) showed that short-course oral treatment with cladribine at cumulative doses of ...
Cited by 4 - Related articles - All 5 versions

Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD

[HTML] from pediatricsdigest.mobiSH Kollins, R Jain, M Brams, S Segal… - …, 2011 - pediatricsdigest.mobi
RESULTS: Of 198 patients randomized, 102 received CLON-XR plus stimulant and 96 received
placebo plus stimulant. At week 5, greater improvement from baseline in ADHD Rating Scale
IV (ADHD-RS-IV) total score (95% confidence interval: −7.83 to −1.13; P = .009), ...
Cited by 2 - Related articles - All 4 versions

Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study

S Cook, P Vermersch, G Comi… - Multiple Sclerosis …, 2011 - msj.sagepub.com
... Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine
Tablets treating multiple sclerosis orallY) study. ... Results: Of the randomized patients, 88.6%
completed treatment with cladribine tablets versus 86.3% with placebo. ...
Cited by 3 - Related articles - All 3 versions

Dissolution Testing of Sublingual Tablets: A Novel In Vitro Method

O Rachid, M Rawas-Qalaji, FER Simons… - AAPS PharmSciTech, 2011 - Springer
Received 22 December 2010; accepted 4 April 2011 Abstract. In the sublingual (SL) cavity, compared
with the gastrointestinal tract, tablets are subjected to minimal physiological agitation, and a limited
volume of saliva is available to facilitate disintegration and dissolution. None of the official ...
Related articles - All 2 versions

[HTML] … indicating liquid chromatographic determination of ebastine in pharmaceuticals after pre column derivatization: Application to tablets and content uniformity …

[HTML] from nih.govF Ibrahim, MKS El-Din, MI Eid… - Chemistry Central …, 2011 - ncbi.nlm.nih.gov
An accurate, simple, sensitive and selective reversed phase liquid chromatographic method
has been developed for the determination of ebastine in its pharmaceutical preparations. The
proposed method depends on the complexation ability of the studied drug with Zn 2+ ...
Cited by 1 - Related articles - All 4 versions

Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and …

[HTML] from thelancet.itG Giovannoni, S Cook, K Rammohan… - The Lancet …, 2011 - Elsevier
On the basis of various clinical and MRI measurements, the phase 3 Cladribine Tablets Treating
Multiple Sclerosis Orally (CLARITY) study in patients with relapsing–remitting multiple sclerosis
(RRMS) showed that short-course oral treatment with cladribine at cumulative doses of ...
Cited by 4 - Related articles - All 5 versions

Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD

[HTML] from pediatricsdigest.mobiSH Kollins, R Jain, M Brams, S Segal… - …, 2011 - pediatricsdigest.mobi
RESULTS: Of 198 patients randomized, 102 received CLON-XR plus stimulant and 96 received
placebo plus stimulant. At week 5, greater improvement from baseline in ADHD Rating Scale
IV (ADHD-RS-IV) total score (95% confidence interval: −7.83 to −1.13; P = .009), ...
Cited by 2 - Related articles - All 4 versions

Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study

S Cook, P Vermersch, G Comi… - Multiple Sclerosis …, 2011 - msj.sagepub.com
... Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine
Tablets treating multiple sclerosis orallY) study. ... Results: Of the randomized patients, 88.6%
completed treatment with cladribine tablets versus 86.3% with placebo. ...
Cited by 3 - Related articles - All 3 versions

美国ACCDON公司旗下品牌

[HTML] … indicating liquid chromatographic determination of ebastine in pharmaceuticals after pre column derivatization: Application to tablets and content uniformity …

[HTML] … indicating liquid chromatographic determination of ebastine in pharmaceuticals after pre column derivatization: Application to tablets and content uniformity …